A detailed history of Insigneo Advisory Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Insigneo Advisory Services, LLC holds 14,064 shares of BMY stock, worth $799,397. This represents 0.07% of its overall portfolio holdings.

Number of Shares
14,064
Previous 20,914 32.75%
Holding current value
$799,397
Previous $995 Million 26.89%
% of portfolio
0.07%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $271,671 - $354,487
-6,850 Reduced 32.75%
14,064 $728 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $128,276 - $168,879
-3,187 Reduced 13.22%
20,914 $995 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $513,002 - $581,644
10,692 Added 79.74%
24,101 $1.31 Billion
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $650,068 - $775,710
13,409 New
13,409 $688 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Insigneo Advisory Services, LLC Portfolio

Follow Insigneo Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insigneo Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insigneo Advisory Services, LLC with notifications on news.